TickerSpark Feed

SNY coverage

Every article, report, and earnings note where SNY appears.

What to Watch as Bambusa Therapeutics Prices Its Nasdaq IPO
IPOBBTX

What to Watch as Bambusa Therapeutics Prices Its Nasdaq IPO

Bambusa Therapeutics Inc. (Nasdaq: BBTX) is expected to list on 2026-10-30, with pricing already set for the NASDAQ. The company has not disclosed a price range, but it sold 10,555,555 shares at $16.00 each for $168.9 million in gross proceeds. Bulls will focus on its long-acting bispecific pipeline in immunology and inflammation; bears will focus on clinical risk and a cash runway that the company says is not enough to fund 12 months of operations.

Oct 27, 20265 MIN
On-Demand Research

Want a deeper dive on SNY?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate SNY Report